My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    1.

    Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes.

    Newton KM, LaCroix AZ, Heckbert SR, Abraham L, McCulloch D, Barlow W.

    Diabetes Care. 2003 Oct;26(10):2810-6.PMID: 14514584 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

    Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ.

    Ann Intern Med. 2000 Dec 19;133(12):933-41.PMID: 11119394 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Postmenopausal estrogens and risk of myocardial infarction in diabetic women.

    Kaplan RC, Heckbert SR, Weiss NS, Wahl PW, Smith NL, Newton KM, Psaty BM.

    Diabetes Care. 1998 Jul;21(7):1117-21.PMID: 9653605 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.

    Ferrara A, Quesenberry CP, Karter AJ, Njoroge CW, Jacobson AS, Selby JV; Northern California Kaiser Permanente Diabetes Registry.

    Circulation. 2003 Jan 7;107(1):43-8.PMID: 12515741 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

    Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH.

    N Engl J Med. 1996 Aug 15;335(7):453-61. Erratum in: N Engl J Med 1996 Oct 31;335(18):1406. PMID: 8672166 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Menopausal hormone replacement therapy and risk of ovarian cancer.

    Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C.

    JAMA. 2002 Jul 17;288(3):334-41. Erratum in: JAMA 2002 Nov 27;288(20):2544. PMID: 12117398 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).

    Robinson JG, Wallace R, Limacher M, Ren H, Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG.

    Am J Cardiol. 2008 Sep 15;102(6):693-9. Epub 2008 Jul 2.PMID: 18773990 [PubMed - indexed for MEDLINE]Related articles

    8.

    Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women.

    Grodstein F, Stampfer MJ, Falkeborn M, Naessen T, Persson I.

    Epidemiology. 1999 Sep;10(5):476-80.PMID: 10468418 [PubMed - indexed for MEDLINE]Related articles

    9.

    Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS).

    Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett-Connor E, Hulley SB.

    Circulation. 2001 Feb 6;103(5):638-42.PMID: 11156873 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy.

    Heckbert SR, Kaplan RC, Weiss NS, Psaty BM, Lin D, Furberg CD, Starr JR, Anderson GD, LaCroix AZ.

    Arch Intern Med. 2001 Jul 23;161(14):1709-13.PMID: 11485503 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.

    Lacey JV Jr, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C.

    Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1724-31.PMID: 16030108 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Estrogen replacement therapy and prognosis after first myocardial infarction.

    Newton KM, LaCroix AZ, McKnight B, Knopp RH, Siscovick DS, Heckbert SR, Weiss NS.

    Am J Epidemiol. 1997 Feb 1;145(3):269-77.PMID: 9012600 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.

    Rosano GM, Fini M.

    Cardiol Rev. 2002 Jan-Feb;10(1):51-60. Review.PMID: 11790270 [PubMed - indexed for MEDLINE]Related articles

    14.

    Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.

    Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P.

    J Natl Cancer Inst. 2006 Oct 4;98(19):1397-405.PMID: 17018786 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study.

    Jonas HA, Kronmal RA, Psaty BM, Manolio TA, Meilahn EN, Tell GS, Tracy RP, Robbins JA, Anton-Culver H.

    Ann Epidemiol. 1996 Jul;6(4):314-23.PMID: 8876842 [PubMed - indexed for MEDLINE]Related articles

    16.

    The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative.

    Newton KM, Buist DS, Miglioretti DL, Beverly K, Hartsfield CL, Chan KA, Andrade SE, Wei F, Connelly MT, Kessler L.

    J Gen Intern Med. 2005 Apr;20(4):350-6.PMID: 15857493 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

    Smith NL, Heckbert SR, Lemaitre RN, Reiner AP, Lumley T, Weiss NS, Larson EB, Rosendaal FR, Psaty BM.

    JAMA. 2004 Oct 6;292(13):1581-7.PMID: 15467060 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of estrogen therapy on gallbladder disease.

    Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC.

    JAMA. 2005 Jan 19;293(3):330-9.PMID: 15657326 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.

    Lacey JV Jr, Leitzmann MF, Chang SC, Mouw T, Hollenbeck AR, Schatzkin A, Brinton LA.

    Cancer. 2007 Apr 1;109(7):1303-11. Erratum in: Cancer. 2007 Aug 15;110(4):937. PMID: 17315161 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.

    Heckbert SR, Weiss NS, Koepsell TD, Lemaitre RN, Smith NL, Siscovick DS, Lin D, Psaty BM.

    Arch Intern Med. 1997 Jun 23;157(12):1330-6.PMID: 9201007 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity